Examine finds elevated survival with nivolumab plus ipilimumab vs. chemo for metastatic colorectal most cancers
For sufferers with microsatellite-instability-high (MSI-H) or mismatch-repair-deficient (dMMR) metastatic colorectal most cancers…
Search
